All Stories

  1. Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass
  2. An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
  3. An update on therapies for the treatment of diabetes-induced osteoporosis